Millenium
Executive Summary
Former Pharmacia Head of Safety Assessment Carl Alden, PhD, joins Millenium as VP-preclinical development. Frank Gentile, PhD, becomes VP-technology program management at Millenium; Gentile previously served as VP-product development at Curis